Short answer
Akebia Therapeutics, Inc. (AKBA) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Second-quarter results for period ended June 30, 2026, with business highlights.
Akebia Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Second-quarter results for period ended June 30, 2026, with business highlights
- Press release furnished as Exhibit 99.1, containing the financial details investors need
- Results announcement provides updated operating performance and business outlook context for AKBA shareholders
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Akebia Therapeutics, Inc. 8-K filings
Get the next AKBA 8-K as it lands
Follow AKBA for push alerts, or ask the research agent what this filing means.